Baird Medical Reports 25% Revenue Growth and Positive Net Income for Six Months Ended June 30, 2026
Baird Medical reported preliminary unaudited first-half 2026 revenue of approximately $9.9 million, up 24.6% from $8.0 million a year earlier, with roughly two-thirds of the total generated outside of China. The company swung to net income of about $14,000 from an $(11.4) million loss in the prior-year period, with EBITDA of roughly $1.6 million and adjusted EBITDA of approximately $4.0 million as gross margin expanded to 87.0% from 82.1%. U.S. contribution jumped to approximately 27% of revenue from under 2% a year ago, and management said the U.S.
Key figures
- Revenue
- 9915407
- Revenue Yoy
- 24.6%
- Ebitda
- 1568077
- Net income
- 13499
- Total opex
- 7776989
- Gross margin
- 87.0%
- Gross profit
- 8623795
- Adjusted ebitda
- 3953077
- Operating income
- 846806
- Us revenue share
- 27%
- Accounts receivable
- 30681684
- Prior year gross margin
- 82.1%
- Cash and restricted cash
- 289083
- Total current liabilities
- 34902327
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.